eMedicine Specialties > Emergency Medicine > Cardiovascular

Hypertensive Emergencies

Author: Christy McCowan, MD, MPH, Assistant Professor, Department of Surgery, University of Utah School of Medicine; Clinical Operations Director, Division of Emergency Medicine, University Health Care; Medical Director, University Health Care Transfer Center
Contributor Information and Disclosures

Updated: Jan 26, 2009

Introduction

Background

Approximately 50 million people in the United States are affected by hypertension (HTN).1,2 Substantial improvements have been made with regards to improving awareness and treatment of hypertension. However, approximately 30% of adults are still unaware of their hypertension; up to 40% of people with hypertension are not receiving treatment; and, of those treated, up to 67% do not have their blood pressure (BP) controlled to less than 140/90 mm Hg.3

New data have shown an increased lifetime risk of hypertension and have also highlighted the increased risk of cardiovascular complications with BP levels previously considered to be normal. Given this information, the Joint National Committee (JNC-7) has introduced a new classification system for hypertension.3

  • Prehypertension - Systolic blood pressure (SBP) 120-139 mm Hg or diastolic blood pressure (DBP) 80-89 mm Hg
  • Stage I hypertension - SBP 140-159 mm Hg or DBP 90-99 mm Hg
  • Stage II hypertension - SBP >160 mm Hg or DBP >100 mm Hg

Hypertensive emergency

Hypertensive emergencies encompass a spectrum of clinical presentations where uncontrolled BPs lead to progressive or impending end-organ dysfunction (EOD). In these conditions, the BP should be lowered aggressively over minutes to hours.

Acute end-organ damage4
  • Neurological
    • Hypertensive encephalopathy
    • Cerebral vascular accident/cerebral infarction
    • Subarachnoid hemorrhage
    • Intracranial hemorrhage
  • Cardiovascular
    • Myocardial ischemia/infarction
    • Acute left ventricular dysfunction
    • Acute pulmonary edema
    • Aortic dissection
  • Other
    • Acute renal failure/insufficiency
    • Retinopathy
    • Eclampsia
    • Microangiopathic hemolytic anemia
With the advent of antihypertensives, the incidence of hypertensive emergencies has declined from 7% to approximately 1% of patients with hypertension.5 In addition, the 1-year survival rate associated with this condition has increased from only 20% (prior to 1950) to a survival rate of more than 90% with appropriate medical treatment.6

Emergency department considerations

Many patients present to the emergency department (ED) with elevated blood pressures; however, only a small proportion of patients will require emergent treatment.

The primary goal of the emergency physician (EP) is to determine which patients with acute hypertension are exhibiting symptoms of end-organ damage and require immediate intravenous parenteral therapy. In contrast, patients presenting with acutely elevated blood pressures (SBP >200 mm Hg or DBP >120 mm Hg) without symptoms require initiation of medical therapy and close follow-up in the outpatient setting.7

Optimal control of hypertensive situations balances the benefits of immediate decreases in BP against the risk of a significant decrease in target organ perfusion. The EP must be capable of the following:

  • Appropriately evaluating patients with an elevated BP
  • Correctly classifying the hypertension
  • Determining the aggressiveness and timing of therapeutic interventions
  • Making disposition decisions

An important point to remember in the management of the patient with any degree of BP elevation is to "treat the patient and not the number."

Pathophysiology

The pathophysiology of hypertensive emergencies is not well understood. Failure of normal autoregulation and an abrupt rise in systemic vascular resistance (SVR) are typically initial steps in the disease process. Increases in SVR are thought to occur from the release of humoral vasoconstrictors from the wall of a stressed vessel. The increased pressure within the vessel then starts a cycle of endothelial damage, local intravascular activation of the clotting cascade, fibrinoid necrosis of small blood vessels, and the release of more vasoconstrictors. If the process is not stopped, a cycle of further vascular injury, tissue ischemia, and autoregulatory dysfunction ensues.8,9

Single-organ involvement is found in approximately 83% of patients presenting with hypertensive emergencies. Two-organ involvement is found in 14% of patients, and multiorgan involvement (>3 organ systems) is found in approximately 3% of patients presenting with a hypertensive emergency.10

The most common clinical presentations of hypertensive emergencies are cerebral infarction (24.5%), pulmonary edema (22.5%), hypertensive encephalopathy (16.3%), and congestive heart failure (12%). Less common presentations include intracranial hemorrhage, aortic dissection, and eclampsia.10

Central nervous system

Cerebral autoregulation is the inherent ability of the cerebral vasculature to maintain a constant cerebral blood flow (CBF) across a wide range of perfusion pressures.

Patients with chronic hypertension can tolerate higher mean arterial pressures (MAP) before they have disruption of their autoregulation system. However, such patients also have increased cerebrovascular resistance and are more prone to cerebral ischemia when flow decreases, especially if blood pressure is decreased into normotensive ranges.

Rapid rises in blood pressure can cause hyperperfusion and increased CBF, which can lead to increased intracranial pressure and cerebral edema.11

Hypertensive encephalopathy is one of the clinical manifestations of cerebral edema and microhemorrhages seen with dysfunction of cerebral autoregulation and is characterized by hypertension, altered mentation, and papilledema.12

Cardiovascular system

Chronic hypertension causes increased arterial stiffness, increased systolic BP, and widened pulse pressures. These factors act to decrease coronary perfusion pressures, increase myocardial oxygen consumption, and lead to left ventricular hypertrophy.12 During hypertensive emergencies, the left ventricle is unable to compensate for an acute rise in systemic vascular resistance. This leads to left ventricular failure and pulmonary edema or myocardial ischemia.4

Renal system

Chronic hypertension causes pathologic changes to the small arteries of the kidney. The arteries develop endothelial dysfunction and impaired vasodilation, which alter renal autoregulation. When the renal autoregulatory system is disrupted, the intraglomerular pressure starts to vary directly with the systemic arterial pressure, thus offering no protection to the kidney during BP fluctuations. During a hypertensive crisis, this can lead to acute renal ischemia.4

Frequency

United States

The prevalence of hypertension in the United States from 2003-2004 was approximately 29.3%.13 Although significant increases have been made in the control of hypertension, the prevalence of the disease has not decreased.

Factors independently associated with hypertension include age older than 40 years, obesity (body mass index >30 kg/m3), and race (non-Hispanic black race).13 Prevalence of the disease increases with advancing age such that approximately half of people aged 60-69 years and three quarters of people aged 70 years or older are affected by hypertension.3

Hypertensive crises affect less than 1% of hypertensive adults in the United States.14

International

Worldwide, approximately 1 billion people have hypertension, contributing to more than 7.1 million deaths per year.15

Mortality/Morbidity

Death from both ischemic heart disease and stroke increase progressively as the BP increases. For every 20 mm Hg systolic or 10 mm Hg diastolic increase in blood pressures above 115/75 mm Hg, the mortality rate for both ischemic heart disease and stroke doubles.3

The morbidity and mortality of hypertensive emergencies depend on the extent of EOD on presentation and the degree to which BP is controlled subsequently. With BP control and medication compliance, the 10-year survival rate of patients with hypertensive crises approaches 70%.16

Race

Hypertension develops at an earlier age, leads to more clinical sequelae, and is more common and severe in African Americans compared with age-matched non-Hispanic whites.17 Hypertensive crises are also more common in African Americans compared with other races.

The prevalence and incidence of hypertension in Mexican Americans are similar to or lower than those in non-Hispanic whites.18 In general, Mexican Americans and Native Americans have lower BP control rates than non-Hispanic whites and African Americans.19

Sex

The lifetime risk for hypertension is 86-90% in females and 81-83% in men.3

Age

Hypertensive crises are more common among elderly persons.

Clinical

History

The history should focus on the presence of end-organ dysfunction (EOD), the circumstances surrounding the hypertension, and any identifiable etiology. The history and physical examination determine the nature, severity, and management of the hypertensive event.

  • Medications
    • Details of antihypertensive drug therapy and compliance
    • Intake of over-the-counter preparations such as sympathomimetic agents
    • Use of illicit drugs such as cocaine
  • Duration and severity of preexisting hypertension
  • Degree of BP control
  • Presence of previous EOD, particularly renal and cerebrovascular disease
  • Date of last menstrual period
  • Other medical problems (eg, prior hypertension, thyroid disease, Cushing disease, systemic lupus, renal disease)
  • Assess whether specific symptoms suggesting EOD are present.

Physical

The physical examination should assess whether EOD is present.

  • Vital signs
    • BP should be measured in both the supine position and the standing position (assess volume depletion).
    • BP should also be measured in both arms (a significant difference may suggest aortic dissection).
  • Ear, nose, and throat (ENT): The presence of new retinal hemorrhages, exudates, or papilledema suggests a hypertensive emergency.
  • Cardiovascular - Evaluate for the presence of heart failure.
    • Jugular venous distension
    • Crackles
    • Peripheral edema
  • Abdomen - Abdominal masses or bruits
  • CNS
    • Level of consciousness
    • Visual fields
    • Focal neurologic signs

Causes

The most common hypertensive emergency is a rapid unexplained rise in BP in a patient with chronic essential hypertension. Most patients who develop hypertensive emergencies have a history of inadequate hypertensive treatment or an abrupt discontinuation of their medications.

More on Hypertensive Emergencies

Overview: Hypertensive Emergencies
Differential Diagnoses & Workup: Hypertensive Emergencies
Treatment & Medication: Hypertensive Emergencies
Follow-up: Hypertensive Emergencies
References

References

  1. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. Jul 9 2003;290(2):199-206. [Medline].

  2. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. Jul 1995;26(1):60-9. [Medline].

  3. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. Dec 2003;42(6):1206-52. [Medline].

  4. Aggarwal M, Khan IA. Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin. Feb 2006;24(1):135-46. [Medline].

  5. Shayne PH, Pitts SR. Severely increased blood pressure in the emergency department. Ann Emerg Med. Apr 2003;41(4):513-29. [Medline].

  6. Rhoades R, Planzer R. Human Physiology. 3rd ed. Fort Worth: Saunders College Publishing; 1996.

  7. Slovis CM, Reddi AS. Increased blood pressure without evidence of acute end organ damage. Ann Emerg Med. Mar 2008;51(3 Suppl):S7-9. [Medline].

  8. Ault MJ, Ellrodt AG. Pathophysiological events leading to the end-organ effects of acute hypertension. Am J Emerg Med. Dec 1985;3(6 Suppl):10-5. [Medline].

  9. Wallach R, Karp RB, Reves JG, Oparil S, Smith LR, James TN. Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: a study of hemodynamic and humoral factors. Am J Cardiol. Oct 1980;46(4):559-65. [Medline].

  10. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension. Jan 1996;27(1):144-7. [Medline].

  11. Kitiyakara C, Guzman NJ. Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol. Jan 1998;9(1):133-42. [Medline].

  12. Heilpern K. Pathophysiology of hypertension. Ann Emerg Med. Mar 2008;51(3 Suppl):S5-6. [Medline].

  13. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. Jan 2007;49(1):69-75. [Medline].

  14. Gudbrandsson T. Malignant hypertension. A clinical follow-up study with special reference to renal and cardiovascular function and immunogenetic factors. Acta Med Scand Suppl. 1981;650:1-62. [Medline].

  15. The world health report 2002-Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; 2002. [Full Text].

  16. Webster J, Petrie JC, Jeffers TA, Lovell HG. Accelerated hypertension--patterns of mortality and clinical factors affecting outcome in treated patients. Q J Med. Aug 1993;86(8):485-93. [Medline].

  17. Cooper R, Rotimi C. Hypertension in blacks. Am J Hypertens. Jul 1997;10(7 Pt 1):804-12. [Medline].

  18. Varon J, Marik PE. Clinical review: the management of hypertensive crises. Crit Care. Oct 2003;7(5):374-84. [Medline].

  19. National Heart, Lung, and Blood Institute. Strong Heart Study Data Book: A Report to American Indian Communities. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 2001.

  20. Decker WW, Godwin SA, Hess EP, Lenamond CC, Jagoda AS,. Clinical policy: critical issues in the evaluation and management of adult patients with asymptomatic hypertension in the emergency department. Ann Emerg Med. Mar 2006;47(3):237-49. [Medline].

  21. Pancioli AM. Hypertension management in neurologic emergencies. Ann Emerg Med. Mar 2008;51(3 Suppl):S24-7. [Medline].

  22. Cheung AT, Hobson RW 2nd. Hypertension in vascular surgery: aortic dissection and carotid revascularization. Ann Emerg Med. Mar 2008;51(3 Suppl):S28-33. [Medline].

  23. Diercks DB, Ohman EM. Hypertension with acute coronary syndrome and heart failure. Ann Emerg Med. Mar 2008;51(3 Suppl):S34-6. [Medline].

  24. Hollander JE. Cocaine intoxication and hypertension. Ann Emerg Med. Mar 2008;51(3 Suppl):S18-20. [Medline].

  25. Barton JR. Hypertension in pregnancy. Ann Emerg Med. Mar 2008;51(3 Suppl):S16-7. [Medline].

  26. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens. Aug 1995;13(8):915-24. [Medline].

  27. Amin A. Parenteral medication for hypertension with symptoms. Ann Emerg Med. Mar 2008;51(3 Suppl):S10-5. [Medline].

  28. Crespo CJ, Loria CM, Burt VL. Hypertension and other cardiovascular disease risk factors among Mexican Americans, Cuban Americans, and Puerto Ricans from the Hispanic Health and Nutrition Examination Survey. Public Health Rep. 1996;111 Suppl 2:7-10. [Medline].

  29. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens. Aug 1995;13(8):915-24. [Medline].

  30. Murphy MB, Murray C, Shorten GD. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med. Nov 22 2001;345(21):1548-57. [Medline].

  31. Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. Jul 29 2000;356(9227):411-7. [Medline].

Further Reading

Keywords

hypertensive emergency, hypertensive emergencies, hypertensive crisis, hypertension, malignant hypertension, HTN, high blood pressure, hypertensive encephalopathy, acute renal ischemia, target organ dysfunction, end-organ dysfunction, severe hypertension, blood pressure control

Contributor Information and Disclosures

Author

Christy McCowan, MD, MPH, Assistant Professor, Department of Surgery, University of Utah School of Medicine; Clinical Operations Director, Division of Emergency Medicine, University Health Care; Medical Director, University Health Care Transfer Center
Christy McCowan, MD, MPH is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Medical Editor

Robin R Hemphill, MD, MPH, Associate Professor, Director, Quality and Safety, Department of Emergency Medicine, Emory University
Robin R Hemphill, MD, MPH is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Gary Setnik, MD, Chair, Department of Emergency Medicine, Mount Auburn Hospital; Assistant Professor, Division of Emergency Medicine, Harvard Medical School
Gary Setnik, MD is a member of the following medical societies: American College of Emergency Physicians, National Association of EMS Physicians, and Society for Academic Emergency Medicine
Disclosure: SironaHealth Salary Management position; South Middlesex EMS Consortium Salary Management position

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

David FM Brown, MD, Assistant Professor, Division of Emergency Medicine, Harvard Medical School; Vice Chair, Department of Emergency Medicine, Massachusetts General Hospital
David FM Brown, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.